2nd Quarter - Report

FOLEY HOAG LLP for OREXIGEN THERAPEUTICS, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Legislative and regulatory matters related to the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) with a focus on the regulation of novel therapeutics for the treatment of obesity.

LobbyistCovered position, as disclosed
J KEVIN BRENNAN —
RODGER CURRIE New —
PAUL KIM —
DAYLE LEWIS CRISTINZIO New Sen Harry Reid, Leg Dir; Rep Steny Hoyer, Sr Leg, Asst; Sen Charles Schumer, Dir Econ Dev&Approp

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.